Ticker Details
Organon & Co..
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - General
Market Cap:	$2.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 1.69%
Avg Daily Range (30 D):	$0.18 | 2.22%
Avg Daily Range (90 D):	$0.16 | 2.14%

Institutional Daily Volume
Avg Daily Volume:	2.58M
Avg Daily Volume (30 D):	5.04M
Avg Daily Volume (90 D):	5.25M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	141
Avg Trade Size (Sh.) (90 D):	150

Institutional Trades
Total Institutional Trades:	4,131
Avg Institutional Trade:	$3.5M
Avg Institutional Trade (30 D):	$2.59M
Avg Institutional Trade (90 D):	$2.98M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.82M
Avg Closing Trade (30 D):	$5.58M
Avg Closing Trade (90 D):	$5.49M
Avg Closing Volume:	421.61K

News

Jan 20, 2026 @ 3:31 PM Sun Pharma Eyes Organon In What Could Be India Pha... Source: Vandana Singh

Dec 11, 2025 @ 6:38 PM Vitally Important: National Women’s Health ... Source: Women'S Health Collective Canada

Dec 11, 2025 @ 6:38 PM Les billets sont maintenant en vente pour Importan... Source: Association Canadienne Pour L'Équité En Santé Des Femmes (Acesf)

Nov 17, 2025 @ 6:00 PM Global Contraceptive Devices Market is Set to Acce... Source: Delveinsight

Nov 4, 2025 @ 7:50 PM Women’s Health Collective Canada and Partne... Source: Amy Flood

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$1.93	$.61	$.56
Diluted EPS	$1.91	$.61	$.56
Revenue	$6.3B	$1.6B	$1.59B
Gross Profit	$3.47B	$857M	$874M
Net Income / Loss	$501M	$160M	$145M
Operating Income / Loss	$702M	$243M	$229M
Cost of Revenue	$2.83B	$745M	$720M
Net Cash Flow	$-91M	$73M	$52M
PE Ratio	4.26